🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →

ZBH NYSE 🇺🇸 US

Zimmer Biomet Holdings, Inc.

Healthcare

Watch

Price Zone: Buy Zone

🔒 Full AI Analysis — Pro

40Score

DipBuster Score™

$88.68 $0.24 (-0.27%) Live price · Source: Yahoo

52-Week Position

$79.12 33% of range $108.29

Beta

0.461

Low vol

Dividend

—

no income

Mkt Cap

N/A

total value

Mkt CapN/A

P/EN/A

DividendNone

Beta0.461

52W High$108.29

52W Low$79.12

DipBuster Brief Key signals at a glance

Zone: Buy Zone

Neutral

Mid-Range Position (33% of 52-Week Range)

The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.

Neutral

Earnings Data Unavailable

P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.

🔓 Sign up free to see 1 more signal →

Valuation

P/E Ratio—

Mkt CapN/A

52W Position33% of range

EV/EBITDA—

Cash Flow

FCF Yield—

FCF / Share

Op. Cash Flow—

Margins

Gross Margin—

Op. Margin—

Net Margin—

Balance Sheet

Cash—

Total Debt—

Net Cash—

Dividend

Yield—

Annual / shNone

Beta0.461

🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.

Charts

Create free account to see financial charts

🕵️ Insiders

📊 Valuation

💰 Dividends

📰 News

🤖 AI Analysis

Recent director dealings and insider transactions at Zimmer Biomet Holdings, Inc. (ZBH), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date	Insider	Type	Shares
2026-06-30	Shapiro Louis	BUY	159
2026-06-30	Kurdikar Devdatt	BUY	180
2026-06-30	Kolli Sreelakshmi	BUY	180
2026-06-30	Hilado Maria Teresa	BUY	389
2026-06-30	Farrell Michael J.	BUY	433
2026-06-30	Hagemann Robert	BUY	317
2026-06-30	Higgins Arthur J	BUY	317
2026-06-01	Noor Jehanzeb	BUY	1,857
2026-05-29	Yi Sang	SELL	800
2026-05-29	Yi Sang	SELL	4,200

Valuation

P/E RatioN/A

Market CapN/A

Beta0.461

Dividend/yrNone

52W High$108.29

52W Low$79.12

52-Week Range

$79.12Now$108.29

33% through annual range

From 52W High−18.1%

From 52W Low+12.1%

📖 Plain English Summary

Zimmer Biomet Holdings, Inc. is at 33% of its 52-week range. Beta 0.461 — tends to move less than the market.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…

Loading dividend data…

Latest news for ZBH 🟢 Bullish ⬜ Neutral 🔴 Bearish

🤖

DipBuster AI Analysis — ZBH

Heuristic · balance sheet, insider filings, price data, academic research

Zimmer Biomet Holdings, Inc. — DipBuster Score 40/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒

Full AI Analysis — Pro

Price zones, Graham analysis, insider signals

Upgrade →

Track Zimmer Biomet Holdings, Inc. free

Add ZBH to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Create free account → Log in

Sponsored · FCA Regulated Broker

Hargreaves Lansdown

UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.

Open Account →

Capital at risk. Your investments can go down as well as up. Disclaimer

DipBuster Score™ Breakdown

Value & P/E 0/30

Dip Position 27/25

Momentum & Volume 8/25

Quality & Size 5/10

Insider Activity 0/10

🎯 Dip Buyer Signal

27 /100 · NEUTRAL

dip depth 22/25

oversold rsi 1/25

mean reversion 4/15

insider zone 0/25

capitulation 0/10

Technical signal only. Not financial advice.

Quick Take

🟡

Watch

DipBuster Score: 40/100

📊 Run a full check in the AI analysis tab for a deeper look.

Full AI analysis ↓ · How scores work

Company Profile

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxill…

Sector Healthcare

Market 🇺🇸 US

CEO Ivan Tornos

Staff 17,000 employees

Website zimmerbiomet.com

Similar Stocks